Paroxetine Tablet, Film Coated
Product Images NDC 68071-2535

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68071-2535). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharamceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 01)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 01)
Chemical structure of paroxetine, shown as a detailed diagram illustrating the molecular bonds, functional groups, and stereochemistry of the active ingredient paroxetine hydrochloride.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 02)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 02)
A chart depicting the fold change and 90% confidence interval for the pharmacokinetic parameters Cmax and AUC of interacting drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg) relative to a reference, shown on a logarithmic scale from 0.1 to 10. The chart compares these changes to the reference value of 1.0.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 03)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 03)
A forest plot chart showing fold changes and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of Paroxetine when interacting with various drugs (Cimetidine 300 mg, Phenobarbital 100 mg, Phenytoin 300 mg, Digoxin 0.25 mg, and Diazepam 5 mg). The chart compares changes relative to a reference value of 1.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 04)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 04)
A forest plot chart displaying pharmacokinetic parameters (Cmax, AUC, Cmin) for various populations, including different degrees of renal impairment, hepatic impairment, age groups over 65 with varying doses, and gender (males). The x-axis represents fold change relative to reference, with data points and 90% confidence intervals shown for each subgroup and parameter.*
FDA Label Image

Pdp (68071 2535 9)

Pdp (68071 2535 9)
Paroxetine 10 mg, film-coated tablets, supplied in a container of 90 tablets. The label shows the product NDC 68071-2535-9 and is manufactured by Cadillac Healthcare Ltd., India, and packaged by NuCare Pharmaceuticals, Inc. Storage instructions specify controlled temperature 68-77°F. The label includes directions to keep out of reach of children and Rx only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.